Dimed Distribuidora de Medicamentos (BSP:PNVL3) Cash per Share: R$1.98 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:PNVL3 Dimed SA Distribuidora de Medicamentos BSP:PNVL3
87 GF Score
Price R$13.16
GF Value R$13.13
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Dimed Distribuidora de Medicamentos Cash per Share?

Dimed Distribuidora de Medicamentos BSP:PNVL3 +2.33% 87 Cash per Share is R$1.98 as of Jun. 2026. GuruFocus rates BSP:PNVL3 with a GF Score™ of 87/100 and a GF Value™ of R$13.13 (Fairly Valued). The stock has 4 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Dimed Distribuidora de Medicamentos's Cash per Share for the quarter that ended in Jun. 2026 was R$1.98.


Dimed Distribuidora de Medicamentos  (BSP:PNVL3) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Dimed Distribuidora de Medicamentos Cash per Share Related Terms


Dimed Distribuidora de Medicamentos Cash per Share Historical Data

* Premium members only.

The historical data trend for Dimed Distribuidora de Medicamentos's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimed Distribuidora de Medicamentos Cash per Share Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.41 1.06 1.65 1.43 2.88

Dimed Distribuidora de Medicamentos Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 2.63 2.88 2.04 1.98
BSP:PNVL3
87GF Score
Dimed SA Distribuidora de Medicamentos BSP:PNVL3
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimed Distribuidora de Medicamentos Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Dimed Distribuidora de Medicamentos's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Dimed Distribuidora de Medicamentos's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of R$1.98 mean?
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Cash per Share of R$1.98 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Dimed Distribuidora de Medicamentos and its competitors.
Is Dimed Distribuidora de Medicamentos' Cash per Share too high?
Dimed Distribuidora de Medicamentos' current Cash per Share is R$1.98. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Cash per Share compare to LLY and JNJ?
Dimed Distribuidora de Medicamentos' Cash per Share of R$1.98 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Drug Manufacturers company?
A good Cash per Share depends on the Drug Manufacturers industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Dimed Distribuidora de Medicamentos and its competitors. Dimed Distribuidora de Medicamentos's current Cash per Share is R$1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Fairly Valued. The stock's GF Value™ is R$13.13, compared to a current price of R$13.16 — trading 0.2% above its estimated fair value. The current Cash per Share is R$1.98. Dimed Distribuidora de Medicamentos' overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Cash per Share is R$1.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?

Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be overvalued. The current stock price of R$13.16 is trading 0.2% above its estimated GF Value™ of R$13.13. GuruFocus considers Dimed Distribuidora de Medicamentos to be Fairly Valued.

Key valuation signals for BSP:PNVL3:

  • Cash per Share: R$1.98
  • GF Value™: R$13.13 vs. price of R$13.16 (0.2% above fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dimed Distribuidora de Medicamentos Business Description

Address Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
87GF Score

Get the complete analysis for BSP:PNVL3

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$13.16
Price
R$13.13
GF Value